What is CIDP?
CIDP is a rare neurological disorder that attacks our body’s nerve fibres, numbing and weakening arm and leg muscles and striking down thousands of Australians – and possibly millions globally.Darkness surrounds the disorder. Currently there is no known therapeutic solution. Or united medical effort to find one.
Get your free CIDP Patient Handbook
By submitting, you agree to be contacted by Klim Foundation regarding CIDP support and updates.
By submitting, you agree to be contacted by Klim Foundation regarding CIDP support and updates.
Klim Foundation
The Klim Foundation is an Australian non-profit organisation founded in 2024 by Olympic swimming legend and CIDP sufferer Michael Klim and entrepreneur Michelle Owen.
The Foundation raises awareness and support for those with CIDP - chronic inflammatory demyelinating polyneuropathy, a rare neurological autoimmune disorder that attacks nerve fibers.
Make an impact
A challenge like this needs champions, including champions like you. We’re going to fight this with every nerve fibre of our being. Whether you are an individual, business or team, there are many ways you can join the fight.
CIDP Patient Handbook
Printing and distribution of CIDP Patient Handbook to be provided to hospitals for patients and doctors.
Earlier Diagnosis & Management
Contribute to aiding earlier diagnosis and management of CIDP through healthcare educational programs.
CIDP Future Leaders Fellowship
Help us establish the future CIDP Leaders Fellowship. This will enable us to support emerging researchers to build careers dedicated to solving CIDP whetehr for early diagnosis or better treatment.
CIDP Connection Events
Donate to enable our in person community support and information events to occur around Australia for those affected by CIDP and their families.
Raise Hope with Us
Your support is the foundation of our mission. By contributing to the Klim Foundation, you help us provide support services, education initiatives for healthcare professionals, advocacy within the community and government for faster diagnosis and improved treatment access, and a platform to raise awareness of this rare disease.
News
Get in Touch
